Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Erweiterte Suche bearbeiten
Filter bei nächster Suche beibehalten
topic_facet:"HIV Infections"
topic_facet:"Recruitment Status: Completed"
topic_facet:"Medical Condition: HIV Infection"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22HIV+Infections%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Completed%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+HIV+Infection%22&join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=ritonavir&type0%5B%5D=AllFields&op0%5B%5D=OR
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22HIV+Infections%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Completed%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+HIV+Infection%22&join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=ritonavir&type0%5B%5D=AllFields&op0%5B%5D=OR
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22HIV+Infections%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Completed%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+HIV+Infection%22&join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=ritonavir&type0%5B%5D=AllFields&op0%5B%5D=OR
PubPharm (26)
1
Strategy for Maintenance of HIV Suppression With Once Daily Integrate Inhibitor+Darunavir/Ritonavir in Children : A Two-arm, Phase 2/3 Multicentre, Open-label, Randomised Study Evaluating Safety and Antiviral Effect of Current Standard Antiretroviral Therapy Compared to Once Daily Integrase Inhibitor Administered With Darunavir/Ritonavir (DRV/r) in HIV-1 Infected, Virologically Suppressed Paediatric Participants.
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
2
A Multicenter Study to Assess the Tolerability of Once Daily Lopinavir/Ritonavir (LPV/r) Liquid Versus Capsules : A Phase IV, Randomized, Open-label Study of the Tolerability of Once Daily Lopinavir/Ritonavir (LPV/r) Liquid Versus Capsules
enthalten in:
ClinicalTrials.gov
| 2020
Wird geladen...
3
A Prospective, Open-label Trial of Two ABC/3TC Based Regimens in Late Presenter naïve Patients (CD4 <200 Cells/µL) : A Prospective, Open-label Trial of Two Abacavir/Lamivudine Based Regimen (ABC/3TC + Darunavir/Ritonavir or ABC/3TC + Raltegravir) in Late Presenter naïve Patients (With CD4 Count <200 Cells/µL - Advanced HIV Disease)
enthalten in:
ClinicalTrials.gov
| 2019
Wird geladen...
4
Switch to Unboosted Atazanavir With Tenofovir Study : Switch to Unboosted Atazanavir With Tenofovir (SUAT) Study
enthalten in:
ClinicalTrials.gov
| 2018
Wird geladen...
5
Pharmacokinetic Characteristics and Anti-Inflammatory Effects of Aprepitant In HIV-Infected Subjects : A Phase IB, Open Label Study to Examine the Safety, Pharmacokinetic Characteristics and Anti-Inflammatory Effects of the NK-1R Antagonist, Aprepitant, In HIV-Infected Subjects Receiving Atazanavir/Ritonavir Or Darunavir/Ritonavir
enthalten in:
ClinicalTrials.gov
| 2017
Wird geladen...
6
ABX464 in Fully Controlled HIV Infected Patients Treated With Boosted Protease Inhibitor Treatment : A Multi-center, Randomized, Double-blind, Placebo-controlled Phase IIa Trial to Compare the Safety of ABX464 Given at a Fixed Dose to Placebo in Fully Controlled HIV Infected Patients Treated With Boosted Protease Inhibitor Treatment (Darunavir/Ritonavir or Darunavir/Cobicistat).
enthalten in:
ClinicalTrials.gov
| 2017
Wird geladen...
7
Study to Evaluate Darunavir/Ritonavir + Lamivudine Versus Continuing With Darunavir/Ritonavir + Tenofovir/Emtricitabine or Abacavir/Lamivudine in HIV Infected Subject : An Open Label Randomized Clinical Trial, to Evaluate the Treatment With Darunavir/Ritonavir + Lamivudine Once Daily Versus Continuing With Darunavir/Ritonavir Once Daily + Tenofovir/Emtricitabine or Abacavir/Lamivudine in HIV Infected Subject With Suppressed Plasma Viremia
enthalten in:
ClinicalTrials.gov
| 2017
Wird geladen...
8
Multicenter, Randomized, Double-Blind, Double-Dummy, Phase 3 Study of the Safety and Efficacy of Elvitegravir Versus Raltegravir : A Multicenter, Randomized, Double-Blind, Double-Dummy, Phase 3 Study of the Safety and Efficacy of Ritonavir-Boosted Elvitegravir (EVG/r) Versus Raltegravir (RAL) Each Administered With a Background Regimen in HIV-1 Infected, Antiretroviral Treatment-Experienced Adults
enthalten in:
ClinicalTrials.gov
| 2016
Wird geladen...
9
Impact of Antiretroviral Therapy on Metabolic, Skeletal, and Cardiovascular Parameters : Cardiovascular, Anthropometric, and Skeletal Effects of Antiretroviral Therapy (ART) Initiation With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) Plus Atazanavir/Ritonavir (ATV/r), Darunavir/Ritonavir (DRV/r), or Raltegravir (RAL): Metabolic Substudy of A5257
enthalten in:
ClinicalTrials.gov
| 2016
Wird geladen...
10
Microboosting of Atazanavir 300 mg With 50 mg Versus 100mg Ritonavir Daily in HIV-infected Patients: a Pharmacokinetic Study : Microboosting of Atazanavir 300 mg With 50 mg Versus 100 mg Ritonavir Daily in HIV-infected Patients: a Pharmacokinetic Study
enthalten in:
ClinicalTrials.gov
| 2015
Wird geladen...
1
2
3
Nächster »
[3]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Thema: HIV Infections
Filter aufheben
Thema: Recruitment Status: Completed
Filter aufheben
Thema: Medical Condition: HIV Infection
Medienart
26
Aufsätze
26
E-Artikel
26
E-Ressourcen
Zeitschriftentitel
26
ClinicalTrials.gov
Thema
26
610
HIV Infections
Medical Condition: HIV Infection
Recruitment Status: Completed
24
Study Type: Interventional
11
Phase: Phase 4
7
Phase: Phase 3
4
Phase: Phase 1
2
Study Type: Observational
1
Phase: Phase 2
1
Phase: Phase 2/Phase 3
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
2
2020-
22
2010-2019
2
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
26
Englisch
Haven't found what you're looking for?
Wird geladen...